Lipid Profiling Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells
Using an Agilent 6546 LC/Q-TOF and MassHunter Lipid Annotator Software
contributed by Agilent Technologies |
The Agilent lipidomics profiling workflow, using the Agilent 6546 LC/Q-TOF and Agilent MassHunter Lipid Annotator software, was applied to the study of drug‑treated acute myeloid leukemia (AML) cells. The results confirmed previously reported observations, and revealed lipid differences made evident through the expanded coverage of this comprehensive workflow.
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!